Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darren Plant

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Annals of the Rheumatic Diseases|June 5, 2012
Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patientsSebastien Viatte, Darren Plant, John Bowes, et al.
The Journal of Rheumatology|April 3, 2012
Heterogeneity of anticitrullinated peptide antibodies and response to anti-tumor necrosis factor agents in rheumatoid arthritisBenjamin A Fisher, Darren Plant, Karin Lundberg, et al.
Annals of the Rheumatic Diseases|November 29, 2013
Investigation of an interleukin-6 receptor gene polymorphism (rs2228145) as a predictor of cardiovascular mortality in inflammatory polyarthritis: results from the Norfolk Arthritis RegisterIbrahim Ibrahim, Kate McAllister, Darren Plant, et al.
Annals of the Rheumatic Diseases|April 20, 2013
Investigation of C reactive protein gene polymorphisms as predictors of cardiovascular mortality in inflammatory polyarthritis: results from the Norfolk Arthritis RegisterIbrahim Ibrahim, Darren Plant, Mark Lunt, et al.
Experimental Dermatology|September 28, 2006
The CX3CL1-CX3CR1 system and psoriasisDarren Plant, Helen S Young, Rachel E B Watson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 8, 2019
Profiling of Gene Expression Biomarkers as a Classifier of Methotrexate Nonresponse in Patients With Rheumatoid ArthritisDarren Plant, Mateusz Maciejewski, Samantha Smith, et al.
Arthritis Care & Research|May 13, 2010
Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodiesTracey M Farragher, Mark Lunt, Darren Plant, et al.
Arthritis Research & Therapy|May 11, 2012
Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritisMarian L Burr, Sebastien Viatte, Marwan Bukhari, et al.
Arthritis Care & Research|May 13, 2010
Association of a rheumatoid arthritis susceptibility variant at the CCL21 locus with premature mortality in inflammatory polyarthritis patientsTracey M Farragher, Darren Plant, Edward Flynn, et al.
Scientific Reports|April 26, 2016
Major histocompatibility complex harbors widespread genotypic variability of non-additive risk of rheumatoid arthritis including epistasisWen-Hua Wei, John Bowes, Darren Plant, et al.
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Annals of the Rheumatic Diseases|June 5, 2012
Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patientsSebastien Viatte, Darren Plant, John Bowes, et al.
The Journal of Rheumatology|April 3, 2012
Heterogeneity of anticitrullinated peptide antibodies and response to anti-tumor necrosis factor agents in rheumatoid arthritisBenjamin A Fisher, Darren Plant, Karin Lundberg, et al.
Annals of the Rheumatic Diseases|November 29, 2013
Investigation of an interleukin-6 receptor gene polymorphism (rs2228145) as a predictor of cardiovascular mortality in inflammatory polyarthritis: results from the Norfolk Arthritis RegisterIbrahim Ibrahim, Kate McAllister, Darren Plant, et al.
Annals of the Rheumatic Diseases|April 20, 2013
Investigation of C reactive protein gene polymorphisms as predictors of cardiovascular mortality in inflammatory polyarthritis: results from the Norfolk Arthritis RegisterIbrahim Ibrahim, Darren Plant, Mark Lunt, et al.
Experimental Dermatology|September 28, 2006
The CX3CL1-CX3CR1 system and psoriasisDarren Plant, Helen S Young, Rachel E B Watson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 8, 2019
Profiling of Gene Expression Biomarkers as a Classifier of Methotrexate Nonresponse in Patients With Rheumatoid ArthritisDarren Plant, Mateusz Maciejewski, Samantha Smith, et al.
Arthritis Care & Research|May 13, 2010
Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodiesTracey M Farragher, Mark Lunt, Darren Plant, et al.
Arthritis Research & Therapy|May 11, 2012
Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritisMarian L Burr, Sebastien Viatte, Marwan Bukhari, et al.
Arthritis Care & Research|May 13, 2010
Association of a rheumatoid arthritis susceptibility variant at the CCL21 locus with premature mortality in inflammatory polyarthritis patientsTracey M Farragher, Darren Plant, Edward Flynn, et al.
Scientific Reports|April 26, 2016
Major histocompatibility complex harbors widespread genotypic variability of non-additive risk of rheumatoid arthritis including epistasisWen-Hua Wei, John Bowes, Darren Plant, et al.
Pageof 11